These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8280948)
1. Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro. Huesca M; Gold B; Sherman P; Lewin P; Lingwood C Zentralbl Bakteriol; 1993 Sep; 280(1-2):244-52. PubMed ID: 8280948 [TBL] [Abstract][Full Text] [Related]
2. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori. Vogt K; Warrelmann M; Hahn H Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
4. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963 [TBL] [Abstract][Full Text] [Related]
5. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori. Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. Bitzan MM; Gold BD; Philpott DJ; Huesca M; Sherman PM; Karch H; Lissner R; Lingwood CA; Karmali MA J Infect Dis; 1998 Apr; 177(4):955-61. PubMed ID: 9534968 [TBL] [Abstract][Full Text] [Related]
7. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Wagstaff AJ; Benfield P; Monk JP Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Gold BD; Huesca M; Sherman PM; Lingwood CA Infect Immun; 1993 Jun; 61(6):2632-8. PubMed ID: 8500901 [TBL] [Abstract][Full Text] [Related]
15. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
16. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs. Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386 [TBL] [Abstract][Full Text] [Related]
17. Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis. Ottlecz A; Romero JJ; Lichtenberger LM Aliment Pharmacol Ther; 1999 Jul; 13(7):875-81. PubMed ID: 10383521 [TBL] [Abstract][Full Text] [Related]
18. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer. Carpintero P; Blanco M; Pajares JM Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352 [TBL] [Abstract][Full Text] [Related]
19. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197 [TBL] [Abstract][Full Text] [Related]